Bioxytran, Inc.https://investorshangout.com/Bioxytran-Inc-BIXT-68137/en-usSat, 12 Sep 2026 22:18:01 GMTCopyright InvestorsHangout.comEcomike: $BIXT news is out. https://finance.yahoo.com/news/bioxytran-secures-source-gmp-quality-145000571.htmhttps://investorshangout.com/post/view?id=6771198https://investorshangout.com/post/view?id=6771198Wed, 18 Jun 2025 15:18:04 GMTEcomike: $BIXT Live conference in 1 hour $BIXT live free conference interview and update 11:30 ESThttps://investorshangout.com/post/view?id=6720480https://investorshangout.com/post/view?id=6720480Thu, 26 Sep 2024 14:26:30 GMTEcomike: Bioxtran has live a online interview at the market open tomorrow, and they cancelled a massive nhttps://investorshangout.com/post/view?id=6714694https://investorshangout.com/post/view?id=6714694Thu, 22 Aug 2024 05:18:31 GMTEcomike: $BIXT seems no one has noticed the dilution S-1 was withdrawn in a recent 8k filing, because they hhttps://investorshangout.com/post/view?id=6710201https://investorshangout.com/post/view?id=6710201Sat, 03 Aug 2024 15:23:06 GMTjacknyak: Bioxytran's ( $BIXT ) market cap of over $18.4M and 165.5M+ outstanding shares demonstrate investor https://investorshangout.com/post/view?id=6675947https://investorshangout.com/post/view?id=6675947Tue, 05 Mar 2024 15:47:43 GMTjacknyak: At a previous price of $0.117, $BIXT remains steadfast in its mission of medical advancement. Throughttps://investorshangout.com/post/view?id=6673946https://investorshangout.com/post/view?id=6673946Mon, 26 Feb 2024 13:29:57 GMTjacknyak: With an average trading volume of 68,287 shares over the last 30 days, Bioxytran ( $BIXT ) garners https://investorshangout.com/post/view?id=6673467https://investorshangout.com/post/view?id=6673467Fri, 23 Feb 2024 12:55:52 GMTJack Mallick: $BIXT is showing remarkable strength with its current trading price of $0.16, marking a substantial https://investorshangout.com/post/view?id=6637928https://investorshangout.com/post/view?id=6637928Fri, 27 Oct 2023 19:25:13 GMTjacknyak: With the market cap at 21,739,916, Bioxytran, Inc. ( $BIXT ) reinforces the importance of oxygen as https://investorshangout.com/post/view?id=6637913https://investorshangout.com/post/view?id=6637913Fri, 27 Oct 2023 18:58:31 GMTtraderrousy: Bioxytran's patent application has the potential to revolutionize antiviral treatments. Their bullishttps://investorshangout.com/post/view?id=6637872https://investorshangout.com/post/view?id=6637872Fri, 27 Oct 2023 17:47:26 GMTnayiralee: Bioxytran, Inc. (BIXT) is making strides in the battle against viruses, with a pending patent applichttps://investorshangout.com/post/view?id=6637772https://investorshangout.com/post/view?id=6637772Fri, 27 Oct 2023 14:20:03 GMTtraderrousy: Bioxytran, Inc. ($BIXT) is changing the game in antiviral research. Their patent application's publihttps://investorshangout.com/post/view?id=6637143https://investorshangout.com/post/view?id=6637143Thu, 26 Oct 2023 14:57:15 GMTnayiralee: With their pending patent application, Bioxytran, Inc. is primed to address a broad spectrum of virahttps://investorshangout.com/post/view?id=6637097https://investorshangout.com/post/view?id=6637097Thu, 26 Oct 2023 14:04:22 GMTtraderrousy: Bioxytran is firmly entrenched in the OTC market with every effort to treat ailments such as inflammhttps://investorshangout.com/post/view?id=6636503https://investorshangout.com/post/view?id=6636503Wed, 25 Oct 2023 13:10:52 GMTnayiralee: Bioxytran, Inc. ($BIXT) aims to redefine healthcare by addressing major challenges like inflammationhttps://investorshangout.com/post/view?id=6636478https://investorshangout.com/post/view?id=6636478Wed, 25 Oct 2023 12:18:51 GMTtraderrousy: The substantial average 30-day trading volume of 152K+ demonstrates the investment community's high https://investorshangout.com/post/view?id=6636173https://investorshangout.com/post/view?id=6636173Tue, 24 Oct 2023 17:48:42 GMTnayiralee: Bioxytran, Inc. ($BIXT) charts its unique path. With diseases like cancer and pulmonary fibrosis in https://investorshangout.com/post/view?id=6636123https://investorshangout.com/post/view?id=6636123Tue, 24 Oct 2023 16:03:04 GMTtraderrousy: The impressive range of Bioxytran, Inc. and its sizable market capitalization highlight its stabilithttps://investorshangout.com/post/view?id=6634814https://investorshangout.com/post/view?id=6634814Fri, 20 Oct 2023 12:57:58 GMTnayiralee: Merging cutting-edge science with smart market strategies, Bioxytran, Inc. ($BIXT) has managed to eshttps://investorshangout.com/post/view?id=6634741https://investorshangout.com/post/view?id=6634741Fri, 20 Oct 2023 11:17:48 GMTtraderrousy: With its cutting-edge technologies and investor confidence, Bioxytran, Inc. ($BIXT) is revolutionizihttps://investorshangout.com/post/view?id=6634368https://investorshangout.com/post/view?id=6634368Thu, 19 Oct 2023 12:27:45 GMTnayiralee: Bioxytran's ($BIXT) pioneering spirit shines in Glycovirology, Hypoxia, and Degenerative Diseases. Thttps://investorshangout.com/post/view?id=6634349https://investorshangout.com/post/view?id=6634349Thu, 19 Oct 2023 12:04:02 GMTtraderrousy: With 144.35M+ outstanding shares, Bioxytran, Inc. ($BIXT) ensures accessibility to a wide range of ihttps://investorshangout.com/post/view?id=6633918https://investorshangout.com/post/view?id=6633918Wed, 18 Oct 2023 12:54:44 GMTnayiralee: Despite the challenges in the pharmaceutical industry, Bioxytran, Inc. stands strong with a market chttps://investorshangout.com/post/view?id=6633914https://investorshangout.com/post/view?id=6633914Wed, 18 Oct 2023 12:47:38 GMTtraderrousy: The market metrics for Bioxytran, Inc.($BIXT) mirror its commitment to pushing the boundaries in medhttps://investorshangout.com/post/view?id=6633540https://investorshangout.com/post/view?id=6633540Tue, 17 Oct 2023 14:15:36 GMTnayiralee: The journey of Bioxytran, Inc.($BIXT) in the OTC market is characterized by its drive to innovate. Thttps://investorshangout.com/post/view?id=6633536https://investorshangout.com/post/view?id=6633536Tue, 17 Oct 2023 14:11:11 GMTtraderrousy: The vision of Bioxytran, Inc. ($BIXT) of extending human life is gaining traction. This journey is hhttps://investorshangout.com/post/view?id=6633086https://investorshangout.com/post/view?id=6633086Mon, 16 Oct 2023 15:45:47 GMTnayiralee: A seamless blend of advanced science and market strategy is Bioxytran, Inc. brings to the table. Thehttps://investorshangout.com/post/view?id=6633007https://investorshangout.com/post/view?id=6633007Mon, 16 Oct 2023 14:55:50 GMTtraderrousy: Bioxytran, Inc. stands out among a slew of biopharmaceutical companies. Their unwavering commitment https://investorshangout.com/post/view?id=6631914https://investorshangout.com/post/view?id=6631914Fri, 13 Oct 2023 11:34:00 GMTnayiralee: Illuminating the path to advanced healthcare, Bioxytran, Inc. ($BIXT) takes a resolute stand with ithttps://investorshangout.com/post/view?id=6631906https://investorshangout.com/post/view?id=6631906Fri, 13 Oct 2023 11:17:05 GMTJack Mallick: $BIXT has maintained a solid market position, evident from its 52-week price range, which ranges frohttps://investorshangout.com/post/view?id=6631507https://investorshangout.com/post/view?id=6631507Thu, 12 Oct 2023 15:56:02 GMTtraderrousy: A look at Bioxytran, Inc.'s market indicators - a substantial market cap of $25.2M+, a consistent trhttps://investorshangout.com/post/view?id=6631141https://investorshangout.com/post/view?id=6631141Thu, 12 Oct 2023 12:00:00 GMTnayiralee: The realm of biopharmaceuticals is vast, but Bioxytran, Inc. carves a unique niche. With their focushttps://investorshangout.com/post/view?id=6631109https://investorshangout.com/post/view?id=6631109Thu, 12 Oct 2023 11:50:10 GMTnayiralee: Investors are buzzing about Bioxytran! With a market cap of $25.4M+ and trading at 0.181, their grouhttps://investorshangout.com/post/view?id=6630570https://investorshangout.com/post/view?id=6630570Wed, 11 Oct 2023 15:28:09 GMTtraderrousy: The 30-day trading volume averaging over 208K+ shares demonstrates active investor engagement. Thishttps://investorshangout.com/post/view?id=6629842https://investorshangout.com/post/view?id=6629842Tue, 10 Oct 2023 11:59:09 GMTnayiralee: Bioxytran, Inc. boasts a robust financial profile on the OTC market. With a market cap exceeding $26https://investorshangout.com/post/view?id=6629825https://investorshangout.com/post/view?id=6629825Tue, 10 Oct 2023 11:23:26 GMTjacknyak: With 300 million authorized shares, Bioxytran, Inc. ($BIXT) has room for growth as they continue to https://investorshangout.com/post/view?id=6629619https://investorshangout.com/post/view?id=6629619Mon, 09 Oct 2023 18:54:03 GMTtraderrousy: With its current trading price of $0.1730 on the OTC, Bioxytran, Inc. ($BIXT) is garnering attentionhttps://investorshangout.com/post/view?id=6629456https://investorshangout.com/post/view?id=6629456Mon, 09 Oct 2023 15:26:25 GMTJack Mallick: $BIXT's commitment to healthcare innovation shines through its work on oxygen therapeutic treatmentshttps://investorshangout.com/post/view?id=6629392https://investorshangout.com/post/view?id=6629392Mon, 09 Oct 2023 14:01:27 GMTnayiralee: Bioxytran, Inc. ($BIXT) takes a bold step into pulmonary fibrosis and stroke treatments. With a markhttps://investorshangout.com/post/view?id=6629378https://investorshangout.com/post/view?id=6629378Mon, 09 Oct 2023 13:49:17 GMTjacknyak: With over 137.77 million outstanding shares and a market cap exceeding $29.62 million, $BIXT is poishttps://investorshangout.com/post/view?id=6622196https://investorshangout.com/post/view?id=6622196Mon, 25 Sep 2023 18:35:30 GMTjacknyak: Trading on the OTC market, Bioxytran, Inc. ($BIXT) opens its mission to a wide range of investors. Whttps://investorshangout.com/post/view?id=6621002https://investorshangout.com/post/view?id=6621002Thu, 21 Sep 2023 15:17:57 GMTJack Mallick: $BIXT is currently trading at $0.20, boasting a substantial 2.56% price upswing. The trading volume https://investorshangout.com/post/view?id=6620733https://investorshangout.com/post/view?id=6620733Wed, 20 Sep 2023 19:30:51 GMTjacknyak: Bioxytran, Inc. ($BIXT) is a game-changer in the treatment of hypoxia, a condition with dire consequhttps://investorshangout.com/post/view?id=6620721https://investorshangout.com/post/view?id=6620721Wed, 20 Sep 2023 19:11:10 GMTJack Mallick: The surge in $BIXT's trading volume to 84.22K reflects growing investor confidence and heightened mahttps://investorshangout.com/post/view?id=6619044https://investorshangout.com/post/view?id=6619044Fri, 15 Sep 2023 16:25:03 GMTJack Mallick: With a market capitalization of $21.12 million, $BIXT's financial stability and long-term vision arehttps://investorshangout.com/post/view?id=6618153https://investorshangout.com/post/view?id=6618153Wed, 13 Sep 2023 18:43:09 GMTJack Mallick: $BIXT's recent price move to $0.16, paired with a surge in trading volume of 197.00K, underscores ithttps://investorshangout.com/post/view?id=6617731https://investorshangout.com/post/view?id=6617731Tue, 12 Sep 2023 19:01:28 GMTJack Mallick: The upward movement in $BIXT's price, currently at $0.175 per share, indicates a positive outlook amhttps://investorshangout.com/post/view?id=6617222https://investorshangout.com/post/view?id=6617222Mon, 11 Sep 2023 16:26:46 GMTJack Mallick: $BIXT is making significant strides in the field of oxygen therapeutic treatments for hypoxic condithttps://investorshangout.com/post/view?id=6616648https://investorshangout.com/post/view?id=6616648Fri, 08 Sep 2023 15:25:19 GMTJack Mallick: $BIXT is making waves with its innovative platform addressing hypoxic conditions and necrosis prevenhttps://investorshangout.com/post/view?id=6616133https://investorshangout.com/post/view?id=6616133Thu, 07 Sep 2023 14:00:26 GMTJack Mallick: $BIXT is a penny stock on the rise in the OTC market. With a market capitalization of $29.03 millionhttps://investorshangout.com/post/view?id=6615888https://investorshangout.com/post/view?id=6615888Wed, 06 Sep 2023 19:16:40 GMT